SCHEMBL203431

SCHEMBL203431

NC(=O)c1cccc(OCCCCOc2ccccc2)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 9/20 0.67
▸ F2 P00734 1/20 0.67
▸ PLG P00747 1/20 0.67
▸ PRSS2 P07478 1/20 0.67
▸ C1S P09871 1/20 0.67
▸ PRSS3 P35030 1/20 0.67
▸ PARP10 Q53GL7 2/20 0.65
▸ KMT2A Q03164 1/20 0.59
▸ PARP1 P09874 1/20 0.57
▸ NR4A2 P43354 1/20 0.55
▸ PLA2G4B P0C869 1/20 0.55
▸ F10 P00742 1/20 0.55
▸ TNKS O95271 1/20 0.54
▸ PARP15 Q460N3 1/20 0.54
▸ PARP14 Q460N5 1/20 0.54
▸ TNKS2 Q9H2K2 1/20 0.54
▸ PARP2 Q9UGN5 1/20 0.54
▸ OPRM1 P35372 1/20 0.54
▸ OPRD1 P41143 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3979585 0.98 PRSS1 (0.65) PRSS1F2PLGPRSS2C1S
SCHEMBL204344 0.90 NR4A2 (0.56) PRSS1F2PLGPRSS2C1S
SCHEMBL203780 0.89 PRSS1 (0.61) PRSS1F2PLGPRSS2C1S
SCHEMBL202127 0.88 FAAH (0.58) PRSS1F2PLGPRSS2C1S
SCHEMBL204302 0.88 FAAH (0.58) PRSS1F2PLGPRSS2C1S
SCHEMBL14791423 0.87 PRSS1 (0.62) PRSS1F2PLGPRSS2C1S
SCHEMBL1387170 0.87 PRSS1 (0.62) PRSS1F2PLGPRSS2C1S
SCHEMBL201955 0.87 PRSS1 (0.62) PRSS1F2PLGPRSS2C1S
SCHEMBL201793 0.87 PRSS1 (0.62) PRSS1F2PLGPRSS2C1S
SCHEMBL7440117 0.87 PRSS1 (0.62) PRSS1F2PLGPRSS2C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179008-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. (US) 2025-06-05 — — US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 — — US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 — — US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 — — US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 — — US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 — — US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 — — US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 — — US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 — — US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 — — US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 — — US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 — — US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 — — US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 — — US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 — — US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 — — US disclosed
EP-1996180-B1 BENZAMIDE AND PYRIDYLAMIDE DERIVATIVES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-08-03 — — EP disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 — — US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 — — US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122918-A1 ANTIBACTERIAL AGENTS ALK, ROS1, ARG1 PRSS1 4371/4885F2 3659/4885PLG 4838/4885
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 PRSS1 3674/4885F2 2751/4885PLG 4851/4885
US-20150191420-A1 ANTIBACTERIAL AGENTS ALK, ARG1, ROS1 PRSS1 4531/4885F2 3895/4885PLG 4841/4885
US-20250179008-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 PRSS1 3674/4885F2 2751/4885PLG 4851/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 PRSS1 3674/4885F2 2751/4885PLG 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback